Role of PARP Inhibition in Ovarian Cancer with Dr Thomas Herzog
Manage episode 350395248 series 2787983
Dr Thomas Herzog from the University of Cincinnati Medical Center in Cincinnati, Ohio, discusses updates and recent changes in the use of PARP inhibitors for ovarian cancer.
CME information and select publications here.
214 episoder